1. Grubman MJ, Baxt B: Foot-and-mouth disease. Clin Microbiol Rev. 2004; 17(2): 465–93. PubMed Abstract | Publisher Full Text | Free Full Text
2. Parida S: Vaccination against foot-and-mouth disease virus: strategies and effectiveness. Expert Rev Vaccines. 2009; 8(3): 347–65. PubMed Abstract | Publisher Full Text
3. Ludi AB, Horton DL, Li Y, et al.: Antigenic variation of foot-and-mouth disease virus serotype A. J Gen Virol. 2014; 95(Pt 2): 384–92. PubMed Abstract | Publisher Full Text
4. Doel TR: Natural and vaccine-induced immunity to foot and mouth disease: the prospects for improved vaccines. Rev Sci Tech. 1996; 15(3): 883–911. PubMed Abstract | Publisher Full Text
5. Grant CF, Carr BV, Singanallur NB, et al.: The B-cell response to foot-and-mouth-disease virus in cattle following vaccination and live-virus challenge. J Gen Virol. 2016; 97(9): 2201–9. PubMed Abstract | Publisher Full Text | Free Full Text
6. Meyer RF, Babcock GD, Newman JF, et al.: Baculovirus expressed 2C of foot-and-mouth disease virus has the potential for differentiating convalescent from vaccinated animals. J Virol Methods. 1997; 65(1): 33–43. PubMed Abstract | Publisher Full Text
7. Sørensen KJ, Hansen CM, Madsen ES, et al.: Blocking ELISAs using the FMDV non-structural proteins 3D, 3AB, and 3ABC produced in the baculovirus expression system. Vet Q. 1998; 20 Suppl 2: S17–20. PubMed Abstract | Publisher Full Text
8. Ferris NP, Grazioli S, Hutchings GH, et al.: Validation of a recombinant integrin αvβ6/monoclonal antibody based antigen ELISA for the diagnosis of foot-and-mouth disease. J Virol Methods. 2011; 175(2): 253–60. PubMed Abstract | Publisher Full Text
9. Shimmon G, Wood BA, Morris A, et al.: Truncated Bovine Integrin Alpha-v/Beta-6 as a Universal Capture Ligand for FMD Diagnosis. PLoS One. 2016; 11(8): e0160696. PubMed Abstract | Publisher Full Text | Free Full Text
10. Fry EE, Newman JW, Curry S, et al.: Structure of Foot-and-mouth disease virus serotype A1061 alone and complexed with oligosaccharide receptor: receptor conservation in the face of antigenic variation. J Gen Virol. 2005; 86(Pt 7): 1909–20. PubMed Abstract | Publisher Full Text
11. Porta C, Kotecha A, Burman A, et al.: Rational engineering of recombinant picornavirus capsids to produce safe, protective vaccine antigen. PLoS Pathog. 2013; 9(3): e1003255. PubMed Abstract | Publisher Full Text | Free Full Text
12. Porta C, Xu X, Loureiro S, et al.: Efficient production of foot-and-mouth disease virus empty capsids in insect cells following down regulation of 3C protease activity. J Virol Methods. 2013; 187(2): 406–12. PubMed Abstract | Publisher Full Text | Free Full Text
13. Madi M, Hamilton A, Squirrell D, et al.: Rapid detection of foot-and-mouth disease virus using a field-portable nucleic acid extraction and real-time PCR amplification platform. Vet J. 2012; 193(1): 67–72. PubMed Abstract | Publisher Full Text
14. Guo HC, Sun SQ, Jin Y, et al.: Foot-and-mouth disease virus-like particles produced by a SUMO fusion protein system in Escherichia coli induce potent protective immune responses in guinea pigs, swine and cattle. Vet Res. 2013; 44: 48. PubMed Abstract | Publisher Full Text | Free Full Text
15. Xiao Y, Chen HY, Wang Y, et al.: Large-scale production of foot-and-mouth disease virus (serotype Asia1) VLP vaccine in Escherichia coli and protection potency evaluation in cattle. BMC Biotechnol. 2016; 16(1): 56. PubMed Abstract | Publisher Full Text | Free Full Text
16. Kuo D, Nie M, Courey AJ: SUMO as a solubility tag and in vivo cleavage of SUMO fusion proteins with Ulp1. Methods Mol Biol. 2014; 1177: 71–80. PubMed Abstract | Publisher Full Text
17. Kotecha A, Seago J, Scott K, et al.: Structure-based energetics of protein interfaces guides foot-and-mouth disease virus vaccine design. Nat Struct Mol Biol. 2015; 22(10): 788–94. PubMed Abstract | Publisher Full Text | Free Full Text
18. Ren J, Cone A, Willmot R, et al.: Assembly of recombinant Israeli Acute Paralysis Virus capsids. PLoS One. 2014; 9(8): e105943. PubMed Abstract | Publisher Full Text | Free Full Text
19. Mateu MG, Escarmís C, Domingo E: Mutational analysis of discontinuous epitopes of foot-and-mouth disease virus using an unprocessed capsid protomer precursor. Virus Res. 1998; 53(1): 27–37. PubMed Abstract | Publisher Full Text
20. Goodwin S, Tuthill TJ, Arias A, et al.: Foot-and-mouth disease virus assembly: processing of recombinant capsid precursor by exogenous protease induces self-assembly of pentamers in vitro in a myristoylation-dependent manner. J Virol. 2009; 83(21): 11275–82. PubMed Abstract | Publisher Full Text | Free Full Text
21. Lewis JK, Bothner B, Smith TJ, et al.: Antiviral agent blocks breathing of the common cold virus. Proc Natl Acad Sci U S A. 1998; 95(12): 6774–8. PubMed Abstract | Publisher Full Text | Free Full Text
22. Lin J, Lee LY, Roivainen M, et al.: Structure of the Fab-labeled "breathing" state of native poliovirus. J Virol. 2012; 86(10): 5959–62. PubMed Abstract | Publisher Full Text | Free Full Text
23. Butan C, Filman DJ, Hogle JM: Cryo-electron microscopy reconstruction shows poliovirus 135S particles poised for membrane interaction and RNA release. J Virol. 2014; 88(3): 1758–70. PubMed Abstract | Publisher Full Text | Free Full Text
24. Xu X, Jones IM: Rapid parallel expression in E. Coli and insect cells: analysis of five lef gene products of the Autographa californica multiple nuclear polyhedrosis virus (AcMNPV). Virus Genes. 2004; 29(2): 191–7. PubMed Abstract | Publisher Full Text
25. Pengelley SC, Chapman DC, Mark Abbott W, et al.: A suite of parallel vectors for baculovirus expression. Protein Expr Purif. 2006; 48(2): 173–81. PubMed Abstract | Publisher Full Text
26. Jones IM: Wellcome Open Research. 2018. Data Source